FIELD: medicine.
SUBSTANCE: preparation contains chemical compound of formula (I) and new amido-substituted imidazoquinolines of formula (I).
EFFECT: enhanced effectiveness of cytokine biosynthesis.
41 cl, 23 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| UREA-SUBSTITUTED IMIDAZOQUINOLINES, PHARMACEUTICAL PREPARATION AND METHOD FOR INDUCTION OF CYTOKINE BIOSYNTHESIS BASED ON THEREOF | 2000 |
|
RU2265020C2 |
| IMIDAZOQUINOLINES, PHARMACEUTICAL PREPARATION AND METHOD FOR INDUCTION OF CYTOKINE BIOSYNTHESIS BASED ON THEREOF | 2000 |
|
RU2248975C2 |
| ARYLETHER-SUBSTITUTED IMIDAZOQUINOLINES, PHARMACEUTICAL COMPOSITIONS BASED ON THE SAME, METHODS FOR TREATMENT OF VIRAL DISEASES BASED ON THE SAME AND METHODS FOR TREATMENT OF TUMOR DISEASE BASED ON THE SAME | 2001 |
|
RU2308456C2 |
| SUBSTITUTED IMIDAZOPYRIDINES | 2001 |
|
RU2294934C2 |
| THIOESTER-SUBSTITUTED IMIDAZOQUINOLINES | 2001 |
|
RU2315049C2 |
| UREA-SUBSTITUTED IMIDAZOQUINOLINE ETHERS | 2001 |
|
RU2302418C2 |
| HETEROCYCLEL ESTER SUBSTITUTED IMIDAZOQUINOLINES | 2001 |
|
RU2351598C2 |
| N-{2-[4-AMINO-2-(ETHOXYMETHYL)-1H-IMIDAZO-[4,5-c]-QUINOLIN-1-YL]-1,1-DIMETHYLETHYL}-METHANESULFONAMIDE AND PHARMACEUTICAL COMPOSITON BASED ON SAID COMPOUND | 2004 |
|
RU2374246C2 |
| PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND | 2021 |
|
RU2819346C1 |
| SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS | 2013 |
|
RU2690663C2 |
